Synfacts, Table of Contents

Synfacts 2024; 20(07): 0760
DOI: 10.1055/s-0043-1763969

Innovative Drug Discovery and Development

LXRβ-Selective Tricyclic Agonist Developed with New [4σ+4π] and [4σ+4π–1] Cycloaddition Strategy

Contributor(s):

Dirk Trauner

,

Joseph A. Flores